普瑞巴林治疗带状疱疹后神经痛65例疗效观察
发布时间:2019-07-06 13:23
【摘要】:目的对比普瑞巴林治疗带状疱疹后神经痛65例疗效进行观察。方法随机选择从2016年10月至2017年10月来我院进行治疗的65例带状疱疹后神经痛患者,65例患者自愿参加本研究活动。将65例患者分为两组,一组为观察组,另一组为对照组,观察组患者30例,对照组患者35例。给观察组患者服用普瑞巴林75-150 mg,每天服用两次治疗带状疱疹后神经痛;给对照组患者进行其他有关药物的服用,每日2-4次口服治疗带状疱疹后神经痛。采用视觉模拟评分(VAS)对两组患者治疗前后疼痛程度的对比,观察周期为2个月。结果经过为期两个月的治疗,两组患者经过不同方案的治疗,带状疱疹后神经痛显有成效,但是观察组的成效高于对照组,差异具有统计学意义(P0.05)。结论普瑞巴林治疗带状疱疹后神经痛出现了非常好的临床效果,提高了患者的睡眠质量,改善了心理疾病,为以后我国医学界治疗带状疱疹后神经痛的研究提供了科学的数据[1]。
[Abstract]:Objective to compare the efficacy of pripramine in the treatment of 65 cases of postherpetic neuropain. Methods 65 patients with postherpetic neuropain who came to our hospital from October 2016 to October 2017 were randomly selected and 65 patients volunteered to participate in the study. Sixty-five patients were divided into two groups. One group was the observation group and the other was the control group. There were 30 patients in the observation group and 35 patients in the control group. The patients in the observation group were treated with Prelabin 75 鈮,
本文编号:2511045
[Abstract]:Objective to compare the efficacy of pripramine in the treatment of 65 cases of postherpetic neuropain. Methods 65 patients with postherpetic neuropain who came to our hospital from October 2016 to October 2017 were randomly selected and 65 patients volunteered to participate in the study. Sixty-five patients were divided into two groups. One group was the observation group and the other was the control group. There were 30 patients in the observation group and 35 patients in the control group. The patients in the observation group were treated with Prelabin 75 鈮,
本文编号:2511045
本文链接:https://www.wllwen.com/yixuelunwen/pifb/2511045.html
最近更新
教材专著